116.11
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
Bears Pounce On Avis Budget, Lucid, MARA — Short Interest In These 10 Stocks Soars Above 40% - Benzinga
Does TransMedics Group's (TMDX) Cash Flow Turn and Fleet Expansion Reshape Its Capital Allocation Story? - Yahoo Finance
TransMedics (TMDX) down 20.3% since last earnings report: Can it rebound? - MSN
TransMedics Group, Inc. $TMDX Position Lifted by Baillie Gifford & Co. - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
How (TMDX) Movements Inform Risk Allocation Models - Stock Traders Daily
Tangible book value per share of TransMedics Group, Inc. – MUN:8T8 - TradingView — Track All Markets
TMDX SEC FilingsTransmedics Group 10-K, 10-Q, 8-K Forms - Stock Titan
RSI Check: Will TransMedics Group Inc benefit from government policy2026 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
A Look at TransMedics Group Inc (TMDX) After 4.4% Gain -- GF Value $177.87 vs Price $114.00 - GuruFocus
Nexstar Media Group Stock Jumps 5% Amid Sector-Wide Rally - AlphaStreet
[ARS] TransMedics Group, Inc. SEC Filing - Stock Titan
TransMedics (NASDAQ: TMDX) details 2025 surge, executive pay and proxy votes - Stock Titan
TMDX Stock Price, Quote & Chart | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
Q4 2025 Transmedics Group Inc Earnings Call Transcript - GuruFocus
Transmedics Group Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says - marketscreener.com
Oppenheimer reiterates TransMedics stock rating amid fuel costs By Investing.com - Investing.com India
Oppenheimer reiterates TransMedics stock rating amid fuel costs - Investing.com
TMDX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Evercore ISI Group Initiates Coverage of TransMedics Group (TMDX) with Outperform Recommendation - MSN
Evercore ISI Group Lowers Price Target for TransMedics Group (TM - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
TransMedics Group, Inc. (TMDX.MX) Insider Ownership & Holdings - Yahoo! Finance Canada
TRANSMEDICS GROUP INC (TMDX) Fundamental Analysis & Valuation - ChartMill
TransMedics Group, Inc. (TMDX) Stock forecasts - Yahoo Finance UK
TransMedics Group Inc (8T8.MU) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TransMedics Group, Inc. (8T8.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect | NDAQ:TMDX | Press Release - Stockhouse
1TMDX.MI Earnings History & Surprises | EPS & Revenue Results | TRANSMEDICS GROUP INC (BIT:1TMDX) - ChartMill
TransMedics’ clinical pipeline to drive next phase of growth - S&P Global
Investors who lost money on TransMedics Group, Inc.(TMDX) should - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Zevenbergen Capital Investments LLC Boosts Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
TransMedics Group (TMDX) price target increased by 10.46% to 164.50 - MSN
[SCHEDULE 13G/A] TransMedics Group, Inc. Amended Passive Investment Disclosure - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
TransMedics Group (TMDX) Is Down 7.1% After Expanding Its National OCS Transplant Platform Ambitions - Yahoo Finance
TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
TransMedics Group, Inc. (TMDX) Stock Forecasts - Yahoo Finance
TransMedics Group (NASDAQ:TMDX) Shares Down 4.5%Here's What Happened - MarketBeat
Reasons to retain TransMedics stock in your portfolio for now - MSN
Consider Keeping TransMedics Shares in Your Portfolio at This Time - Bitget
Reasons to Retain TransMedics Stock in Your Portfolio for Now - finance.yahoo.com
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Group (STU:TMDX) NonCurrent Deferred Revenue : €0.0 Mil (As of Dec. 2025) - GuruFocus
TransMedics Group, Inc. Sued for Securities Law ViolationsInve - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect - ACCESS Newswire
TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push - MarketBeat
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect | NDAQ:TMDX | Press Release - Stockhouse
A Look At TransMedics Group (TMDX) Valuation After Share Pullback And Insider Selling Reports - simplywall.st
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):